| Filed On | Filing |
|---|---|
| 12 Aug 2026 |
Form 3: Duatschek Stephanie, EVP, CGO
Holds 197,416 shares of Common Stock |
| 05 Mar 2026 |
Form 3: Fowler John D Jr, Director
Holds 0 shares of Common Stock |
| 21 Nov 2024 |
Form 3: Lowry Simon C, SVP, R&D, CMO
Holds 0 shares of Common Stock |
| 12 Nov 2024 |
Form 3: Perl Jessica, SVP, General Counsel, Corp Sec
Holds 6,805 shares of Common Stock |
| 29 Feb 2024 |
Form 3: Papa Joseph C, Director
Holds 0 shares of Common Stock |
| 05 Oct 2023 |
Form 3: Fowler Neal Franklin, Director
Holds 0 shares of Common Stock |
| 05 Oct 2023 |
Form 3: DeGolyer Donald W, Director
Holds 0 shares of Common Stock |
| 15 Aug 2023 |
Form 3: Hartzel William, SVP, Bioservices
Holds 35,917 shares of Common Stock |
| 18 Jul 2023 |
Form 3: Miller H Haywood Iii, Interim CEO
Holds 0 shares of Common Stock |
| 18 Jan 2023 |
Form 3: Williams Paul Anthony, SVP, Products Business
Holds 9,376 shares of Common Stock |
| 22 Jul 2022 |
Form 3: Dayal Sujata Tyagi, Director
Holds 0 shares of Common Stock |
| 05 Apr 2022 |
Form 3: Katkin Keith, Director
Holds 0 shares of Common Stock |
| 25 Mar 2022 |
Form 3: Glessner Coleen, EVP, Quality & Ethics, and CPL
Holds 0 shares of Common Stock |
| 03 Mar 2022 |
Form 3: Fox Jennifer Lynne, EVP, Ext Aff, GC, Corp Sec
Holds 7,250 shares of Common Stock |
| 05 Oct 2020 |
Form 3: White Marvin L, Director
Holds 0 shares of Common Stock |
| 28 May 2020 |
Form 3: Smith Karen L., EVP, Chief Medical Officer
Holds 6,310 shares of Common Stock |
| 03 Jun 2019 |
Form 3: Emergent BioSolutions Inc., Sean Kirk, EVP, Manufacturing
Holds 13,604 shares of Common Stock |
| 21 Mar 2019 |
Form 3: Mulligan Seamus, Director
Holds 48,572 shares of Common Stock |
| 03 Apr 2018 |
Form 3: Lindahl Richard S, EVP, Chief Financial Officer
No securities owned |
| 21 Jul 2017 |
Form 3: Saran Atul, EVP, Corp Dev, GC & Secretary
No securities owned |
Loading...
